...
首页> 外文期刊>Journal of ocular pharmacology and therapeutics: The official journal of the Association for Ocular Pharmacology and Therapeutics >A Randomized Controlled Trial Comparing Dexamethasone with Loteprednol Etabonate on Postoperative Photorefractive Keratectomy
【24h】

A Randomized Controlled Trial Comparing Dexamethasone with Loteprednol Etabonate on Postoperative Photorefractive Keratectomy

机译:地塞米松与洛佩特诺依他巴坦治疗术后屈光性角膜切除术的随机对照试验

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Purpose: To compare loteprednol etabonate 0.5%/tobramycin 0.3% (Zylet((R))) with dexamethasone 0.1%/tobramycin 0.3% (Tobradex((R))) in terms of the epithelial healing time, postoperative visual acuity, corneal haziness score, and intraocular pressure (IOP) in postoperative treatment after photorefractive keratectomy (PRK).
机译:目的:在上皮愈合时间,术后视力,角膜混浊方面,比较乐透心宁0.5%/妥布霉素0.3%(Zylet(R))和地塞米松0.1%/妥布霉素0.3%(Tobradex(R))。评分和眼压(IOP)在屈光性角膜切除术(PRK)术后的治疗中。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号